Views 514
Citations 0
Editor's Note
October 2014

It’s Not Just About the Money, Money, Money…

Author Affiliations

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2014;174(10):1696. doi:10.1001/jamainternmed.2014.3374

Global funding for biomedical research now approaches $270 billion per year, nearly two-thirds of which comes from industry, including pharmaceutical, biotechnology, and medical device companies.1 While industry’s investment in research has spawned breakthroughs and innovations, these investments have also fueled concerns that industry-funded clinical trials are more likely to have proindustry conclusions,2 potentially distorting the evidence base to favor more expensive, brand name products on which manufacturers continue to spend research dollars.

First Page Preview View Large
First page PDF preview
First page PDF preview